Target intelligence / Profile preview

Ribosomal protein S27 pseudogene 12 (RPS27P12)

Target
RPS27P12
Molecular classification
Other
01

Overview

Ribosomal protein S27 pseudogene 12 (RPS27P12) is a processed pseudogene, not coding a functional protein, and is one of several pseudogenes derived from the active ribosomal protein S27 gene. Pseudogenes do not produce functional protein products and are not known to play direct biological roles. They are often catalogued for genomic annotation but are not considered therapeutic targets or functional biomolecules[2][5][7]. Context and supporting details: - RPS27P12 is annotated in genomic databases as a pseudogene, meaning it is a non-functional copy or derivative of the true ribosomal protein S27 gene (RPS27)[2][5][7]. - The canonical, functional gene is RPS27, which encodes a component of the 40S ribosomal subunit involved in protein synthesis, and has evidence linking it to cancer and ribosome function[3][6][8]. - RPS27P12 itself does not encode a protein, has no described function, does not interact with drugs, and plays no known role in disease or as a biomarker[2][5][7]. - Pseudogenes like RPS27P12 are plentiful for ribosomal proteins and typically arise from gene duplication or retrotransposition events[3][4][6]. - If a query is about RPS27P12 as a therapeutic target, it is incorrect: RPS27P12 is not a drug target and has no therapeutic relevance. Summary of key findings: RPS27P12 is not a functional target, not a receptor or enzyme, and has no curated biological or clinical function. It is a pseudogene, and while RPS27 (its parent gene) is functionally important, RPS27P12 itself is not. Therefore, if this pseudogene was selected as a "target", that would be a mistake[2][5][7].

Other names
RPS27_4_403[5][7]

Beyond the preview

Go deeper on Ribosomal protein S27 pseudogene 12 (RPS27P12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S27 pseudogene 12 (RPS27P12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call